Oct 29, 2021 | Compliance, Legal, and Malpractice, International Laboratory News, Laboratory Pathology, Laboratory Resources, Laboratory Testing, Management & Operations, Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing
CDC advises clinical laboratories and microbiologists encountering C. auris to follow their own protocols before adopting federal agency guidelines In July, the Centers for Disease Control and Prevention (CDC) warned healthcare facilities and clinical laboratories to be on the alert for Candida auris (C. auris) infections in their patients. An outbreak of the drug resistant and potentially deadly fungus had appeared in two Dallas hospitals and a Washington D.C. nursing home. Since those...
